• 1
    Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998;69: 505510.
  • 2
    Lass A, Skull J, McVeigh E, Margara R, Winston RM. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in vitro fertilisation can predict poor response. Hum Reprod 1997;12: 220223.
  • 3
    Tomas C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilisation. Hum Reprod 1997;12: 220223.
  • 4
    Banci L, Broekmans F, Eijkemans M, de Jong F, Habbema D, Velde E. Predictors in poor ovarian response in in vitro fertilisation: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77: 328336.
  • 5
    Danforth DR, Arbogast LK, Mroueh J, et al. Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 1998;70: 119123.
  • 6
    Seifer DB, Scott RT, Bergh PA, et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle stimulating hormone. Fertil Steril 1999;72: 6365.
  • 7
    Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 1999;14: 409415.
  • 8
    Creus M, Penarrubia J, Fabregues F, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000;15: 23412346.
  • 9
    Kligman I, Rosenwaks Z. Differentiating clinical profiles: predicting good responders, poor responders and hyper responders. Fertil Steril 2001;76: 11851190.
  • 10
    Ficicioglu C, Kutlu T, Demirbasoglu S, Mulayim B. The role of inhibin B as a basal determinant of ovarian reserve. Gynecol Endocrinol 2003;17: 287293.
  • 11
    Van Rooij IAJ, Broekmans FJM, te Velde ER, et al. Serum anti mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17: 30653071.
  • 12
    Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81: 14011405.
  • 13
    Cook CL, Siow Y, Taylor S, Fallat ME. Serum Mullerian inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000;73: 859861.
  • 14
    Scott Jr RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63: 111.
  • 15
    Barnhart K, Osheroff J. Follicle stimulating hormone as a predictor of fertility. Curr Opin Obstet Gynecol 1998;10: 227232.
  • 16
    Ueno S, Kuroda T, Maclaughlin DT, Ragin RC, Manganaro TF, Danahoe PK. Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle. Endocrinology 1989;125: 10601066.
  • 17
    Vigier B, Picard JY, Tran D, Legeai L, Josso N. Production of anti Mullerian hormone: another homology between sertoli and granulosa cells. Endocrinology 1984;114: 13151320.
  • 18
    Laven J, Mulders A, Visser J, Themmen A, De Jong F, Fauser B. Ano-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004;89: 318323.
  • 19
    Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex specific gene expression. Cell 1998;93: 445454.
  • 20
    Arango NA, Lovell-Badge R, Behringer RR. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 1999;99: 409419.
  • 21
    Tremblay JJ, Robert NM, Viger RS. Modulation of endogenous GATA-4 activity reveals its dual contribution to Mullerian inhibiting substance gene transcription in sertoli cells. Mol Endocrinol 2001;15: 16361650.
  • 22
    De Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Anti mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77: 357362.
  • 23
    Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycle. Fertil Steril 2002;77: 468471.